Plus Therapeutics (PSTV) Treasury Shares (2011 - 2026)
Plus Therapeutics (PSTV) reported Treasury Shares of $500000.0 for Q1 2026, little changed year-over-year from $500000.0 in Q1 2025, and little changed quarter-over-quarter from $500000.0 in Q4 2025.
Plus Therapeutics (PSTV) Treasury Shares (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 4 years of Treasury Shares data on file, last reported at $500000.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $500000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $500000.0 (changed 0.0% YoY), and the FY2025 annual result was $500000.0, changed 0.0% from the prior year.
- Treasury Shares steadied at $500000.0 in Q1 2026 per PSTV's latest filing, from $500000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $2.8 million in Q3 2025 and troughed at -$258425.0 in Q1 2024.
- A 4-year average of $195430.3 and a median of -$44448.0 in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares soared 296.83% in 2024, then changed 0.0% in 2025.
- A 4-year view of Treasury Shares shows it stood at $126000.0 in 2023, then soared by 296.83% to $500000.0 in 2024, then changed by 0.0% to $500000.0 in 2025, then changed by 0.0% to $500000.0 in 2026.
- Business Quant data shows PSTV's Treasury Shares at $500000.0 in Q1 2026, $500000.0 in Q4 2025, and $500000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | 253,042.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253,042.00 |
| Mar 31, 2026 | 253,042.00 |
| Mar 31, 2026 | 500,000.00 |
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 10,337.00 |
| Dec 31, 2025 | 10,337.00 |
| Dec 31, 2025 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 2.82 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Jun 30, 2025 | -258,425.00 |
| Jun 30, 2025 | -258,425.00 |
| Mar 31, 2025 | -10,337.00 |
| Mar 31, 2025 | -10,337.00 |
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |